Zhang Binfeng, Lang Zekun, Zhang Lei, Gao Boxiong, Wang Yutong, Liu Yatao
Department of Anesthesia and Surgery, First Hospital of Lanzhou University, No. 1 Donggang West Road, Chengguan District, Lanzhou, Gansu, 730000, People's Republic of China.
The First Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, People's Republic of China.
Eur J Med Res. 2025 Apr 15;30(1):285. doi: 10.1186/s40001-025-02558-8.
In endoscopic retrograde cholangiopancreatography anesthesia, both intubation and non-intubation techniques have their own advantages and disadvantages. However, whether either approach is associated with postoperative and anesthesia-related adverse events remains controversial.
We searched the literature in PubMed, Web of Science, Cochrane Library, Scopus, Ovid and Embase databases up to October 2024. All studies comparing intubated vs. non-intubation anesthesia for endoscopic retrograde cholangiopancreatography were included. The main outcome measures were sedation-related adverse events and death. Data were combined using risk ratio with 95% confidence intervals. The study protocol was prospectively registered with PROSPERO (CRD42024608807).
We finally included 8 studies with a total of 21,433 patients. Endotracheal intubation was associated with a lower risk of sedation-related adverse events (RR: 2.85, 95% CI 1.33-6.09, p = 0.007). However, the risks of death (RR: 0.59, 95% CI 0.36-0.96, p = 0.03) and intraoperative hypotension (RR: 0.43, 95% CI 0.26-0.69, p = 0.0006) were lower without intubation. In the trial-sequence analysis, the trial-sequence monitoring boundary is crossed, indicating conclusive evidence of a statistically significant effect.
Our findings suggest that endotracheal intubation during endoscopic retrograde cholangiopancreatography is associated with a lower risk of sedation-related adverse events but a higher risk of mortality and intraoperative hypotension compared to non-intubation. However, these associations do not establish direct causality and should be interpreted with caution. Further high-quality randomized controlled trials are needed to validate these findings. Clinicians should adopt a patient-centered approach, carefully balancing the potential benefits and risks of intubation to optimize airway management strategies in endoscopic retrograde cholangiopancreatography.
在内镜逆行胰胆管造影术麻醉中,插管和非插管技术都有各自的优缺点。然而,这两种方法是否与术后及麻醉相关不良事件有关仍存在争议。
我们检索了截至2024年10月的PubMed、Web of Science、Cochrane图书馆、Scopus、Ovid和Embase数据库中的文献。纳入所有比较内镜逆行胰胆管造影术插管麻醉与非插管麻醉的研究。主要结局指标为镇静相关不良事件和死亡。采用风险比及95%置信区间合并数据。该研究方案已在PROSPERO(CRD42024608807)进行前瞻性注册。
我们最终纳入8项研究,共21433例患者。气管插管与较低的镇静相关不良事件风险相关(风险比:2.85,95%置信区间1.33 - 6.09,p = 0.007)。然而,非插管时死亡风险(风险比:0.59,95%置信区间0.36 - 0.96,p = 0.03)和术中低血压风险(风险比:0.43,95%置信区间0.26 - 0.69,p = 0.0006)较低。在试验序贯分析中,越过了试验序贯监测边界,表明有统计学显著效应的确凿证据。
我们的研究结果表明,与非插管相比,内镜逆行胰胆管造影术期间气管插管与较低的镇静相关不良事件风险相关,但死亡风险和术中低血压风险较高。然而,这些关联并未确立直接因果关系,应谨慎解读。需要进一步的高质量随机对照试验来验证这些发现。临床医生应采取以患者为中心的方法,仔细权衡插管的潜在益处和风险,以优化内镜逆行胰胆管造影术的气道管理策略。